Histone recognition and large-scale structural analysis of the human bromodomain family

  • Cell. 2012 Mar 30;149(1):214-31. doi: 10.1016/j.cell.2012.02.013.
Panagis Filippakopoulos  1 ,  Sarah Picaud ,  Maria Mangos ,  Tracy Keates ,  Jean-Philippe Lambert ,  Dalia Barsyte-Lovejoy ,  Ildiko Felletar ,  Rudolf Volkmer ,  Susanne Müller ,  Tony Pawson ,  Anne-Claude Gingras ,  Cheryl H Arrowsmith ,  Stefan Knapp
Affiliations
  • 1. Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7LD, UK. [email protected]
Abstract

Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all Brd families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new Brd substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing Peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.